Literature DB >> 23071861

Emergence of HA mutants during influenza virus pneumonia.

Maria Eugenia Vázquez Manríquez1, Akiko Makino, Motoko Tanaka, Yasuhisa Abe, Hiroyuki Yoshida, Ichiro Morioka, Soichi Arakawa, Yasuhiro Takeshima, Kentaro Iwata, Jin Takasaki, Toshie Manabe, Takaaki Nakaya, Shota Nakamura, Anjarath Lorena Higuera Iglesias, Rosa Maria Rivera Rossales, Erika Pena Mirabal, Tateki Ito, Toshio Kitazawa, Teruaki Oka, Makoto Yamashita, Koichiro Kudo, Kyoko Shinya.   

Abstract

During the influenza pandemic of 2009, the number of viral pneumonia cases showed a marked increase in comparison with seasonal influenza viruses. Mutations at amino acid 222 (D222G mutations) in the virus hemagglutinin (HA) molecule, known to alter the receptor-recognition properties of the virus, were detected in a number of the more severely-affected patients in the early phases of the pandemic. To understand the background for the emergence of the mutant amino acid D222G in human lungs, we conducted histological examinations on lung specimens of patients from Mexico who had succumbed in the pandemic. Prominent regenerative and hyperplastic changes in the alveolar type II pneumocytes, which express avian-type sialoglycan receptors in the respiratory tract of severely affected individuals, were observed in the Mexican patients. An infection model utilizing guinea pigs, which was chosen in order to best simulate the sialic acid distribution of severe pneumonia in human patients, demonstrated an increase of D222G mutants and a delay in the diminution of mutants in the lower respiratory tract in comparison to the upper respiratory tract. Our data suggests that the predominance of avian-type sialoglycan receptors in the pneumonic lungs may contribute to the emergence of viral HA mutants. This data comprehensively illustrates the mechanisms for the emergence of mutants in the clinical samples.

Entities:  

Keywords:  Influenza; hemagglutinin; hyperplastic pneumocytes; mutant; pneumonia; syaloglycan receptor

Mesh:

Substances:

Year:  2012        PMID: 23071861      PMCID: PMC3466977     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  27 in total

1.  Bacteriology and histopathology of the respiratory tract and lungs in fatal Asian influenza.

Authors:  J F HERS; N MASUREL; J MULDER
Journal:  Lancet       Date:  1958-11-29       Impact factor: 79.321

Review 2.  Avian influenza A (H5N1) infection in humans.

Authors:  John H Beigel; Jeremy Farrar; Aye Maung Han; Frederick G Hayden; Randy Hyer; Menno D de Jong; Sorasak Lochindarat; Thi Kim Tien Nguyen; Tran Hien Nguyen; Tinh Hien Tran; Angus Nicoll; Sok Touch; Kwok-Yung Yuen
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

Review 3.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

4.  Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities.

Authors:  James Stevens; Ola Blixt; Laurel Glaser; Jeffery K Taubenberger; Peter Palese; James C Paulson; Ian A Wilson
Journal:  J Mol Biol       Date:  2005-11-18       Impact factor: 5.469

5.  Anti-mycobacterial natural products from the Canadian medicinal plant Juniperus communis.

Authors:  Caitlyn D Carpenter; Taryn O'Neill; Nadia Picot; John A Johnson; Gilles A Robichaud; Duncan Webster; Christopher A Gray
Journal:  J Ethnopharmacol       Date:  2012-08-01       Impact factor: 4.360

6.  Both influenza hemagglutinin and polymerase acidic genes are important for delayed pandemic 2009 H1N1 virus clearance in the ferret model.

Authors:  Mariette F Ducatez; Natalia A Ilyushina; Thomas P Fabrizio; Jerold E Rehg; Nicolai V Bovin; Robert G Webster; Richard J Webby
Journal:  Virology       Date:  2012-07-17       Impact factor: 3.616

7.  Case report: Increased viral receptor expression associated with high viral load and severe pneumonia in a young patient infected with 2009 H1N1 influenza a with no pre-existing conditions.

Authors:  Chompunuch Boonarkart; Ratapum Champunot; Mongkol Uiprasertkul; Charatdao Bunthi; Sumalee Kiatboobsri; Mana Rochanawutanon; Suchat Porncharoenpong; Ornpreya Suptawiwat; Prasert Auewarakul
Journal:  J Med Virol       Date:  2012-03       Impact factor: 2.327

8.  Characteristics of influenza virus genome mutations.

Authors:  Motoko Tanaka; Kyoko Tsumura; Hiroshi Ito; Toshihiro Ito; Etsuro Ono; Akiko Makino; Yoshihiro Kawaoka; Kyoko Shinya
Journal:  Kobe J Med Sci       Date:  2012-01-16

9.  Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics.

Authors:  Y Kawaoka; S Krauss; R G Webster
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

10.  Influenza A H5N1 replication sites in humans.

Authors:  Mongkol Uiprasertkul; Pilaipan Puthavathana; Kantima Sangsiriwut; Phisanu Pooruk; Kanittar Srisook; Malik Peiris; John M Nicholls; Kulkanya Chokephaibulkit; Nirun Vanprapar; Prasert Auewarakul
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

View more
  1 in total

1.  H3N2 Virus as Causative Agent of ARDS Requiring Extracorporeal Membrane Oxygenation Support.

Authors:  Adriano Peris; Giovanni Zagli; Pasquale Bernardo; Massimo Bonacchi; Morena Cozzolino; Lucia Perretta; Alberta Azzi; Giovanni Cianchi
Journal:  Case Rep Med       Date:  2014-01-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.